Factors Associated with Reported COVID-like Symptoms and Seroprevalence Data Matched with COVID-like Symptoms in Slums and Non-Slums of Two Major Cities in Bangladesh

To examine the levels and socio-demographic differentials of: (a) reported COVID-like symptoms; and (b) seroprevalence data matched with COVID-like symptoms. Survey data of reported COVID-like symptoms and seroprevalence were assessed by Roche Elecsys Anti-SARS-CoV-2 immunoassay. Survey data of 10,0...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Healthcare (Basel) 2023-05, Vol.11 (10), p.1444
Hauptverfasser: Razzaque, Abdur, Huda, Tarique Mohammad Nurul, Chowdhury, Razib, Haq, Md Ahsanul, Sarker, Protim, Akhtar, Evana, Billah, Md Arif, Islam, Mohammad Zahirul, Hoque, Dewan Md Emdadul, Ahmed, Shehlina, Ahmed, Yasmin H, Tofail, Fahmida, Raqib, Rubhana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To examine the levels and socio-demographic differentials of: (a) reported COVID-like symptoms; and (b) seroprevalence data matched with COVID-like symptoms. Survey data of reported COVID-like symptoms and seroprevalence were assessed by Roche Elecsys Anti-SARS-CoV-2 immunoassay. Survey data of 10,050 individuals for COVID-like symptoms and seroprevalence data of 3205 individuals matched with COVID-like symptoms were analyzed using bivariate and multivariate logistic analysis. The odds of COVID-like symptoms were significantly higher for Chattogram city, for non-slum, people having longer years of schooling, working class, income-affected households, while for households with higher income had lower odd. The odds of matched seroprevalence and COVID-like symptoms were higher for non-slum, people having longer years of schooling, and for working class. Out of the seropositive cases, 37.77% were symptomatic-seropositive, and 62.23% were asymptomatic, while out of seronegative cases, 68.96% had no COVID-like symptoms. Collecting community-based seroprevalence data is important to assess the extent of exposure and to initiate mitigation and awareness programs to reduce COVID-19 burden.
ISSN:2227-9032
2227-9032
DOI:10.3390/healthcare11101444